Validation of a French questionnaire for cystic fibrosis patients
Official title: French Validation of the AdT-Physio Scale for Assessing Adherence and Perception of the Intervention of a Physiotherapist in Patients With Cystic Fibrosis
Run by Pole Sante Grace de Dieu · NCT06273566 · Data updated 2026-11-12
This study is testing a new French questionnaire to see if it can help young adults with cystic fibrosis stick to their physiotherapy treatments better.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 100 Years |
| Sex | All |
| Enrollment | 121 (estimated) |
| Sponsor | Pole Sante Grace de Dieu Academic / other |
| Locations | 1 site (Caen) |
| Status | Recruiting |
| Started | April 1, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | September 18, 2026 |
| Trial ID | NCT06273566 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are cystic fibrosis patients over 18 years old who are not lung transplant recipients and can complete the questionnaires.
✕Probably not a fit
Patients who are under 18 years old or have undergone a lung transplant may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to translate and validate the AdT-Physio scale into French, assessing its effectiveness as a tool for evaluating adherence to physiotherapy among cystic fibrosis patients. Participants will complete the French version of the AdT-Physio scale, along with the Brief Cope and GSES questionnaires. The study focuses on young adults aged 16 to 21, a demographic known for low adherence to physiotherapy treatments. By validating this scale, the study seeks to provide physiotherapists with a reliable method to evaluate treatment adherence and patient perceptions.
Why it matters
Potential benefit: If successful, this study could enhance the management of cystic fibrosis by improving adherence to physiotherapy, thereby potentially increasing patients' quality of life.
How similar studies have gone: Previous studies have successfully validated similar adherence assessment tools in other languages, indicating potential for success with this French version.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: The subjects recruited are patients with cystic fibrosis, over 18 years old, without a lung transplant and able to answer the questionnaires.
Where it's running
-
Psla Gdd
Caen, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Inhaled CFTR mRNA for cystic fibrosis in Chinese patients aged 12 and older
This trial tests inhaled BMD003, a CFTR mRNA therapy, to see if it's safe and shows early signs of benefit in Chinese people 12 years and up with cystic fibrosis.
-
VX-272 dose escalation in healthy adults
This will test single and multiple increasing doses of the experimental drug VX-272 in healthy adults to see how safe it is and how the body handles it.
-
Prevalence of smoking, passive smoke exposure, and vaping among adults with cystic fibrosis
This project will see how common smoking, exposure to secondhand smoke, and vaping are among adults with cystic fibrosis followed at the Strasbourg Adult CF Center.
-
Dose escalation of VX-581 to check safety and drug levels in healthy adults
The trial will test increasing doses of VX-581 in healthy adults to see if it is safe and to measure how the body absorbs and clears the drug.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Collecting sputum samples at home for cystic fibrosis patients
This study is testing if collecting sputum samples at home can help people with cystic fibrosis better identify lung infections compared to traditional methods done at the clinic.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.